Literature DB >> 26929388

Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells.

Raymond Liang1,2, Pauline Rimmelé1, Carolina L Bigarella1, Safak Yalcin1, Saghi Ghaffari1,2,3,4,5.   

Abstract

Transcription factors FOXOs (1, 3, 4) are essential for the maintenance of haematopoietic stem cells. FOXOs are evolutionary conserved substrates of the AKT serine threonine protein kinase that are also phosphorylated by several kinases other than AKT. Specifically, phosphorylation by AKT is known to result in the cytosolic localization of FOXO and subsequent inhibition of FOXO transcriptional activity. In addition to phosphorylation, FOXOs are regulated by a number of other post-translational modifications including acetylation, methylation, redox modulation, and ubiquitination that altogether determine these factors' output. Cumulating evidence raises the possibility that in stem cells, including in haematopoietic stem cells, AKT may not be the dominant regulator of FOXO. To address this question in more detail, we examined gene expression, subcellular localization, and response to AKT inhibition of FOXO1 and FOXO3, the main FOXO expressed in HSPCs (haematopoietic stem and progenitor cells). Here we show that while FOXO1 and FOXO3 transcripts are expressed at similar levels, endogenous FOXO3 protein is mostly nuclear compared to the cytoplasmic localization of FOXO1 in HSPCs. Furthermore, inhibition of AKT does not enhance nuclear localization of FOXO1 nor FOXO3. Nonetheless AKT inhibition in the context of loss of NAD-dependent SIRT1 deacetylase modulates FOXO3 localization in HSPCs. Together, these data suggest that FOXO3 is more active than FOXO1 in primitive haematopoietic stem and multipotent progenitor cells. In addition, they indicate that upstream regulators other than AKT, such as SIRT1, maintain nuclear FOXO localization and activity in HSPCs.

Entities:  

Keywords:  AKT; FOXO; FOXO1; FOXO3; SIRT1; Sirtuins; acetylation; deacetylation; hematopoietic stem and progenitor cells

Mesh:

Substances:

Year:  2016        PMID: 26929388      PMCID: PMC4845935          DOI: 10.1080/15384101.2015.1123355

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a.

Authors:  Diego H Castrillon; Lili Miao; Ramya Kollipara; James W Horner; Ronald A DePinho
Journal:  Science       Date:  2003-07-11       Impact factor: 47.728

3.  FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.

Authors:  Blanca Scheijen; Hai T Ngo; Hyun Kang; James D Griffin
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

4.  SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress.

Authors:  Yosuke Kobayashi; Yoko Furukawa-Hibi; Chen Chen; Yoshiyuki Horio; Kenichi Isobe; Kyoji Ikeda; Noboru Motoyama
Journal:  Int J Mol Med       Date:  2005-08       Impact factor: 4.101

5.  Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification.

Authors:  Taisuke Hosaka; William H Biggs; David Tieu; Antonia D Boyer; Nissi M Varki; Webster K Cavenee; Karen C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

6.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

7.  Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.

Authors:  Hiroaki Daitoku; Mitsutoki Hatta; Hitomi Matsuzaki; Satoko Aratani; Takayuki Ohshima; Makoto Miyagishi; Toshihiro Nakajima; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

8.  FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1).

Authors:  Armando van der Horst; Leon G J Tertoolen; Lydia M M de Vries-Smits; Roy A Frye; René H Medema; Boudewijn M T Burgering
Journal:  J Biol Chem       Date:  2004-05-04       Impact factor: 5.157

9.  NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a.

Authors:  Ting-Lei Gu; Zuzana Tothova; Blanca Scheijen; James D Griffin; D Gary Gilliland; David W Sternberg
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

10.  Mammalian SIRT1 represses forkhead transcription factors.

Authors:  Maria Carla Motta; Nullin Divecha; Madeleine Lemieux; Christopher Kamel; Delin Chen; Wei Gu; Yvette Bultsma; Michael McBurney; Leonard Guarente
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

View more
  17 in total

Review 1.  Mitochondria and FOXO3 in stem cell homeostasis, a window into hematopoietic stem cell fate determination.

Authors:  Raymond Liang; Saghi Ghaffari
Journal:  J Bioenerg Biomembr       Date:  2017-06-21       Impact factor: 2.945

2.  Cellular differentiation: Potential insight into butyrate paradox?

Authors:  Stacy H Ryu; Gerard E Kaiko; Thaddeus S Stappenbeck
Journal:  Mol Cell Oncol       Date:  2018-02-27

3.  FOXO activity adaptation safeguards the hematopoietic stem cell compartment in hyperglycemia.

Authors:  Vinothini Govindarajah; Jung-Mi Lee; Michael Solomon; Bryan Goddard; Ramesh Nayak; Kalpana Nattamai; Hartmut Geiger; Nathan Salomonis; Jose A Cancelas; Damien Reynaud
Journal:  Blood Adv       Date:  2020-11-10

4.  The PI3K pathway impacts stem gene expression in a set of glioblastoma cell lines.

Authors:  Eduardo Martinez; Neftali Vazquez; Alma Lopez; Victor Fanniel; Lilia Sanchez; Rebecca Marks; Leetoria Hinojosa; Victoria Cuello; Marisa Cuevas; Angelica Rodriguez; Cerin Tomson; Andrea Salinas; Mark Abad; Martin Holguin; Noel Garza; Abraham Arenas; Kevin Abraham; Luis Maldonado; Vivian Rojas; Alex Basdeo; Erin Schuenzel; Michael Persans; Wendy Innis-Whitehouse; Megan Keniry
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-06       Impact factor: 4.553

Review 5.  Transcription factors FOXO in the regulation of homeostatic hematopoiesis.

Authors:  Vijay Menon; Saghi Ghaffari
Journal:  Curr Opin Hematol       Date:  2018-07       Impact factor: 3.284

6.  FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage.

Authors:  Carolina L Bigarella; Jianfeng Li; Pauline Rimmelé; Raymond Liang; Robert W Sobol; Saghi Ghaffari
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

Review 7.  Signaling Pathways in Leukemic Stem Cells.

Authors:  Lindsay M Gurska; Kristina Ames; Kira Gritsman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 8.  Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.

Authors:  Raymond Liang; Saghi Ghaffari
Journal:  Br J Haematol       Date:  2016-07-21       Impact factor: 6.998

9.  FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivation.

Authors:  Andrew E Hale; Donna Collins-McMillen; Erik M Lenarcic; Suzu Igarashi; Jeremy P Kamil; Felicia Goodrum; Nathaniel J Moorman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-21       Impact factor: 11.205

10.  NVP-BEZ235 or JAKi Treatment leads to decreased survival of examined GBM and BBC cells.

Authors:  Neftali Vazquez; Alma Lopez; Victoria Cuello; Michael Persans; Erin Schuenzel; Wendy Innis-Whitehouse; Megan Keniry
Journal:  Cancer Treat Res Commun       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.